Abstract: The use in the medical-surgical field of biomaterials based on hyaluronic acid derivatives, optionally in association with natural, synthetic or semisynthetic biopolymers, for suppressing the angiogenic process associated with tumor proliferation (in primary and secondary tumors) is disclosed.
Abstract: The present invention relates to a method for determining the concentration of a first molecule having a chemical structure, which contains a first peptide sequence comprising: (a) obtaining a sample containing the first molecule, (b) providing a reference sample which contains a second molecule having a certain concentration and chemical structure, which contains a second peptide sequence, wherein the chemical structure of the second molecule only differs from the structure of the first molecule in one or more permutations in the first peptide sequence, (c) combining the reference sample and the sample containing the first molecule, (d) identifying at least one fragment peak in a mass spectrum (MS) of the first molecule and the second molecule, wherein the mass difference of the fragment peaks is only caused by the permutation of the at least two different amino acids, and (e) determining the concentration of the first molecule relative to the certain concentration of the second molecule by comparing of the
Abstract: The invention relates to a method and device for operating collimator (1) for limiting a beam of high-energy radiation (2) which, starting from an essentially point-shaped radiation source (3), is directed onto an object (4) to be treated and which is used especially for stereotactic, conformal radiation therapy of tumors, wherein the collimator (1) has an iris diaphragm (5) as a beam-limiting means.
Type:
Application
Filed:
May 5, 2010
Publication date:
October 28, 2010
Applicant:
Deutsches Krebsforschungszentrum Stiftung des Oeffentlichen Rechts
Abstract: Provided is a method for monitoring the presence and/or progression of prostate tumor in an individual, by measuring the expression level of marker genes out of a novel signature of 39 genes. The invention further discloses a data base and array comprising said identified marker genes for prognosing the tumor progression in an individual suffering from prostate cancer.
Type:
Application
Filed:
September 12, 2007
Publication date:
October 14, 2010
Applicant:
Deutsches Krebsforschungszentrum Stiftung des öffentkuchen Rechts
Inventors:
Annemarie Poustka, Fritz Poustka, Andreas Buness, Markus Ruschhaupt, Holger Sueltmann, Thorsten Schlomm, Olaf Hellwinkel
Abstract: The invention relates to a dual-modality imaging system and a method for dual-modality imaging, wherein a positron emission tomography (PET) scanner for acquiring PET imaging data and at least one optical imaging detector for acquiring optical imaging data are arranged to acquire the PET imaging data and the optical imaging data of an imaged object (5) simultaneously (i.e. at the same time and at superimposed fields-of-view). The at least one optical imaging detector is a non-contact optical imaging detector.
Type:
Grant
Filed:
April 10, 2006
Date of Patent:
August 31, 2010
Assignee:
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
Abstract: An irradiation device for radiation treatment and a collimator (1) are used to define a beam of high-energy rays (2) with beam limitation by means of an iris diaphragm (5) having adjusting elements (7), and a mechanism that is used to direct the beams (2?) limited by the collimator (1) to the object to be treated (4) from all sides, wherein the parameters for direction, surface area, intensity and time of irradiation can be specified with the help of a control mechanism. An exact three-dimensional irradiation profile is produced, while keeping the costs and efforts regarding mechanical engineering, computation and irradiation time low.
Type:
Grant
Filed:
July 27, 2006
Date of Patent:
August 24, 2010
Assignee:
Deutsches Krebsforschungszentrum Stiftung des öeffentlichen Rechts
Abstract: The present invention relates to an optical scanning device that comprises a light source to emit a beam of light, and a beam splitter to split that beam into several beamlets, and further a first objective lens to direct said beamlets onto a focal plane wherein each of said beamlets impinges on the focal plane spacially separated from each other, wherein the beam splitter comprises several birefringent elements for splitting said beam, preferably a stack of Wollaston prisms.
Type:
Grant
Filed:
March 31, 2006
Date of Patent:
June 29, 2010
Assignee:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
Abstract: The present invention relates to fusion polypeptides including (a) a binding site for a cytoskeleton component and (b1) an effector protein or the catalytic domain thereof or (b2) a binding site for the effector protein, and nucleic acid sequences encoding the fusion polypeptides. Moreover, various therapeutic uses of the fusion polypeptides are described, e.g., the treatment of diseases associated with the presence of an aberrant cell population, preferably cancer or AIDS.
Type:
Application
Filed:
July 1, 2009
Publication date:
June 10, 2010
Applicant:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
Abstract: The present invention relates to an antibody active against a fusion polypeptide comprising a histidine portion, a process for the preparation thereof and its use.
Type:
Grant
Filed:
May 14, 2009
Date of Patent:
May 11, 2010
Assignee:
Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts
Abstract: Described are DNA sequences encoding an E6 or E7 fusion protein of HPV, wherein said DNA sequences are characterized by a combination of the following features: original codons are exchanged by codons which lead to an enhanced translation in a mammalian cell, they contain a deletion resulting in the production of a truncated non-functional protein, and they encode a fusion partner which is a highly immunogenic polypeptide capable of enhancing the immunogenicity of the E6 or E7 protein in the mammalian host. Furthermore, the modified E6 or E7 protein encoded by said DNA sequences as well as expression vectors containing said DNA sequences are described as well as several uses of the these compounds.
Type:
Grant
Filed:
April 10, 2007
Date of Patent:
April 20, 2010
Assignee:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
Abstract: An embodiment is directed to a method and a system for assisting the targeting of a target with an elongate instrument, wherein the instrument is to be inserted into a living object's body part along a predetermined trajectory extending between an entry point of said instrument into said body part and a target point associated with said target. The method comprises an instrument directing assisting step for generating and displaying an image allowing a user to assess to which extend the longitudinal axis of the instrument is aligned with the vector connecting the target point and the tip portion of said instrument. Also, the method comprises an instrument guiding assisting step of generating and displaying an image allowing a user to assess to which extent the instrument motion during insertion thereof coincides with the predetermined trajectory.
Type:
Application
Filed:
June 10, 2009
Publication date:
March 25, 2010
Applicant:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
Inventors:
Lena Maier-Hein, Alexander Seitel, Ivo Wolf, Hans Peter Meinzer
Abstract: A method is described for the diagnosis of an ovarian or endometrial tumor or for a prognosis, characterized in that the L1 level is determined in a patient sample, preferably via an anti L1 antibody, the presence of L1 being an indication of the presence of an ovarian or endometrial tumor or a predisposition for such a tumor. Furthermore, methods for treating of ovarian or endometrial tumors are provided.
Type:
Grant
Filed:
October 2, 2007
Date of Patent:
March 2, 2010
Assignees:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts, Mor Research Applications, Ltd.
Abstract: The invention relates to a triple-modality imaging system, wherein an optical imaging detector for acquiring optical tomography imaging data, a single photon emission computered tomography (SPECT) detector for acquiring SPECT data, and an x-ray source and detector for acquiring x-ray data are arranged to acquire optical imaging data, SPECT data, and x-ray data of an imaged object simultaneously, the optical imaging detector, the SPECT detector, and the x-ray detector having spatially over-lapping fields-of-view (FOV).
Abstract: The present invention provides a composition comprising (a) a parvovirus NS1 protein and (b) a parvovirus VP1 protein. Furthermore, the present invention provides DNA sequences encoding said proteins. The composition of the invention is useful for the preparation of a toxin for treating tumoral diseases.
Type:
Application
Filed:
September 30, 2009
Publication date:
February 4, 2010
Applicant:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
Inventors:
Laurent Daeffler, Jurg Nuesch, Jean Rommelaere
Abstract: The present invention relates to a process for linking two molecules by means of a Diels Alder reaction with inverse electron requirement (DARinv), comprising the following steps: reaction of a (a) triazine or tetrazine with one or more electron-attracting substituents on the ring as a diene component, the electron-attracting substituents being selected from: COOR C(O)NR2 CX3 (X=halogen) halogen CN SO2—R or SO3—R PR2 wherein R?H, alkyl, aryl, heterocycle, which in turn may be substituted, where appropriate, with alkyl, OH, SH, halogen, aryl, heterocycle, nitro, carboxyamido or amine group.
Type:
Application
Filed:
June 18, 2007
Publication date:
January 21, 2010
Applicant:
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS
Inventors:
Manfred Wiessler, Eduard Müller, Peter Lorenz, Christian Kliem, Heinz Fleischhacker
Abstract: The present invention relates to a database storage structure for the storage of a plurality of results from an experiment on a sample. The database storage structure includes a result storage table for storing the results from the experiment, one or more first annotation storage tables for storing a first set of variables, and one or more second annotation storage tables for storing a second limited set of variables. The one or more second annotation storage tables are further coupled to one or more concordance tables for storing a concordance between the second limited set of variables and a second list of annotations.
Type:
Grant
Filed:
October 2, 2002
Date of Patent:
January 19, 2010
Assignee:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts
Abstract: A method is described for the diagnosis of an ovarian or endometrial tumor or for a prognosis, characterized in that the L1 level is determined in a patient sample, preferably via an anti L1 antibody, the presence of L1 being an indication of the presence of an ovarian or endometrial tumor or a predisposition for such a tumor. Furthermore, methods for treating of ovarian or endometrial tumors are provided.
Type:
Grant
Filed:
July 10, 2001
Date of Patent:
November 17, 2009
Assignees:
Deutsches Krebsforschungszentrum Stiftung des Offentlichen Rechts, Mor Research Applications, Ltd.
Abstract: The present invention relates to a cell culture medium comprising (a) an inhibitor of bone morphogenetic protein-4 (BMP-4) and (b) an inhibitor of pigment epithelium-derived factor (PEDF, also known as SerpinF1). In one embodiment, the inhibitors are antibodies against BMP-4 and PEDF, respectively. The medium allows to culture keratinocytes under non-differentiating conditions. The invention also relates to corresponding methods and kits. As the media and methods disclosed allow for an improved manufacture of keratinocytes, the invention also relates to the treatment of skin wounds and to the manufacture of corresponding medicaments. This will be of advantage for treatment e.g. of burns, ulcers, etc., in which transplantation of keratinocytes or skin is required.
Type:
Application
Filed:
September 7, 2007
Publication date:
November 12, 2009
Applicant:
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
Inventors:
Axel Szabowski, Peter Angel, Julia Knebel
Abstract: The invention relates to a method for producing computer tomography images from limited data of a region of interest of an image object which can be subject to changes, comprising the steps of a) producing a first computer tomography image of the region of interest (source image) by acquiring a sufficient set of projection data and using a standard CT-image reconstruction technique, b) selecting at least one transformation function depending on expected changes of the image object, c) acquiring CT-data of the image object from a limited number of projections under a limited range of observation angles, d) reconstructing a new image of the region of interest (target image) by an iterative procedure starting from the source image of the region of interest, deforming the source image by using the transformation function and optimizing the target image in view of the acquired CT-data from the limited number of projections.
Type:
Grant
Filed:
July 15, 2005
Date of Patent:
November 10, 2009
Assignee:
Deutsches Krebsforschungszentrum
Inventors:
Valeriy Vengrinovich, Yuri Denkevich, Wolfgang Schlegel, Bernd Hesse